参考文献/References:
[1] Zhou Y,Que KT,Zhang Z,et al. Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway[J]. Cancer Med,2018,7(8):4012-4022.
[2] Jiang X,Stockwell BR,Conrad M. Ferroptosis:mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol,2021,22(4):266-282.
[3] Bellelli R,Federico G,Matte’ A,et al. NCOA4 deficiency impairs systemic iron homeostasis[J]. Cell Rep,2016,14(3):411-421.
[4] Wang YQ,Chang SY,Wu Q,et al. The protective role of mitochondrial ferritin on erastin-induced ferroptosis[J]. Front Aging Neurosci,2016,8:308.
[5] Doll S,Proneth B,Tyurina Y,et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol,2017,13(1):91-98.
[6] Stockwell BR,Friedmann Angeli JP,Bayir H,et al. Ferroptosis:a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017,171(2):273-285.
[7] Liu Z,Lv X,Song E,et al. Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis[J]. Toxicol Appl Pharmacol,2020,407:115241.
[8] Kerins MJ,Ooi A. The roles of NRF2 in modulating cellular iron homeostasis[J]. Antioxid Redox Signal,2018,29(17):1756-1773.
[9] 方学贤,蔡昭贤,王浩,等. 铁过载及铁死亡在心脏疾病中的研究进展[J]. 科学通报,2019,64(Z2):2974-2987.
[10] Baba Y,Higa JK,Shimada BK,et al. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes[J]. Am J Physiol Heart Circ Physiol,2018,314(3):H659-H668.
[11] Fang X,Cai Z,Wang H,et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis[J]. Circ Res,2020,127(4):486-501.
[12] Park TJ,Park JH,Lee GS,et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes[J]. Cell Death Dis,2019,10(11):835.
[13] Tang LJ,Luo XJ,Tu H,et al. Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion[J]. Naunyn Schmiedebergs Arch Pharmacol,2021,394(2):401-410.
[14] Feng Y,Madungwe NB,Imam Aliagan AD,et al. Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels[J]. Biochem Biophys Res Commun,2019,520(3):606-611.
[15] Li W,Li W,Leng Y,et al. Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stre ss[J]. DNA Cell Biol,2020,39(2):210-225.
[16] Li W,Feng G,Gauthier JM,et al. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation[J]. J Clin Invest,2019,129(6):2293-2304.
[17] Chen HY,Xiao ZZ,Ling X,et al. ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy[J]. Mol Med,2021,27(1):14.
[18] Kamat P,Vandenberghe S,Christen S,et al. Dexrazoxane shows no protective effect in the acute phase of reperfusion during myocardial infarction in pigs[J]. PLoS One,2016,11(12):e0168541.
[19] Miotto G,Rossetto M,di Paolo ML,et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1[J]. Redox Biol,2020,28:101328.
[20] Fang X,Wang H,Han D,et al. Ferroptosis as a target for protection against cardiomyopathy[J]. Proc Natl Acad Sci U S A,2019,116(7):2672-2680.
[21] Shan X,Lv ZY,Yin MJ,et al. The Protective effect of cyanidin-3-glucoside on myocardial ischemia-reperfusion injury through ferroptosis[J]. Oxid Med Cell Longev,2021,2021:8880141.
[22] Li T,Tan Y,Ouyang S,et al. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis[J]. Gene,2022,808:145968.
[23] Bayraktar A,Erba? D,Akarca Dizakar S?,et al. The effect of hepcidin on cardiac ischemia-reperfusion injury[J]. J Invest Surg,2020,33(9):813-821.
[24] Fan Z,Cai L,Wang S,et al. Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis[J]. Front Pharmacol,2021,12:628988.
[25] Fuhrmann DC,Mondorf A,Beifu? J,et al. Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis[J]. Redox Biol,2020,36:101670.
[26] Wang P,Cui Y,Ren Q,et al. Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosis[J]. Cell Death Dis,2021,12(5):447.
[27] Maccarinelli F,Gammella E,Asperti M,et al. Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity[J]. J Mol Med (Berl),2014,92(8):859-869.
[28] Wu W,Chang S,Wu Q,et al. Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury[J]. Cell Death Dis,2016,7(11):e2475.
[29] Liu J,Yang M,Kang R,et al. Autophagic degradation of the circadian clock regulator promotes ferroptosis[J]. Autophagy,2019,15(11):2033-2035.
[30] Stamenkovic A,O’Hara KA,Nelson DC,et al. Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury[J]. Am J Physiol Heart Circ Physiol,2021,320(3):H1170-H1184.
[31] Ma S,Sun L,Wu W,et al. USP22 protects against myocardial ischemia-reperfusion injury via the SIRT1-p53/SLC7A11-dependent inhibition of ferroptosis-induced cardiomyocyte death[J]. Front Physiol,2020,11:551318.
[32] Song Y,Wang B,Zhu X,et al. Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice[J]. Cell Biol Toxicol,2021,37(1):51-64.
相似文献/References:
[1]张馨月 涂荣会.Toll样受体与心肌缺血再灌注损伤及其保护作用研究进展[J].心血管病学进展,2020,(2):172.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.018]
ZHANG Xinyue,TU Ronghui.Review Onprotective Effects of Toll-like Receptors on Myocardial Ischemia Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(4):172.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.018]
[2]张明 王敬萍.Nur77和GRP78与糖尿病心肌缺血再灌注损伤的关系研究[J].心血管病学进展,2020,(6):571.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.003]
ZHANG Ming Wang Jingping.Relationship between Nur77 and GRP78 and Myocardial Ischemia-reperfusion Injury in Diabetic Patients[J].Advances in Cardiovascular Diseases,2020,(4):571.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.003]
[3]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong. Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(4):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[4]郭双 邢栋 吕勃.程序性坏死、细胞焦亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
GUO Shuang,XING Dong,LYU Bo.NecroptosisPyroptosis and Myocardial Ischemia-reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(4):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
[5]袁明明 赖松青 张泽宇 吴起才.铁死亡在脓毒症心脏功能损伤中的研究进展[J].心血管病学进展,2022,(1):26.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.007]
YUAN mingmingLAI SongqingZHANG ZeyuWU Qicai.Ferroptosis in Cardiac Function Impairment in Sepsis[J].Advances in Cardiovascular Diseases,2022,(4):26.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.007]
[6]彭可玲 贾晓艳 王华 刘永铭.铁死亡与心力衰竭的研究进展[J].心血管病学进展,2022,(5):432.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
PENG Keling,JIA Xiaoyan,WANG Hua,et al.Ferroptosis and Heart Failure[J].Advances in Cardiovascular Diseases,2022,(4):432.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
[7]邵亚兰 马继鹏 卢林鹤 熊祥 马燕燕 刘金成 杨剑.铁死亡与铁自噬在中的研究进展[J].心血管病学进展,2022,(9):787.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
SHAO Yalan,MA Jipeng,LU Linhe,et al.Ferroptosis and Ferritinophagy in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2022,(4):787.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
[8]郭双 吕勃.细胞凋亡和程序性坏死在心肌缺血再灌注损伤中的作用研究[J].心血管病学进展,2022,(12):1148.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.020]
GUO Shuang L YU Bo.The Role of Apoptosis and Necroptosis in Myocardial Ischemia-Reperfusion Injury[J].Advances in Cardiovascular Diseases,2022,(4):1148.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.020]
[9]孙悦 付松波 李亦兰.心肌细胞铁死亡及其检测方法[J].心血管病学进展,2023,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.016]
SUN Yue,FU Songbo,LI Yilan.Methods for the Detection of Ferroptosis in Cardiomyocytes[J].Advances in Cardiovascular Diseases,2023,(4):167.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.016]
[10]王文杰 杨嘉馨 丁耀东 王可馨 牛佳龙 葛海龙.铁死亡在心血管疾病中的研究进展[J].心血管病学进展,2023,(5):420.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.009]
WANG Wenjie,YANG Jiaxin,DING Yaodong,et al.Ferroptosis in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(4):420.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.009]
[11]叶宇恒 钱玲玲 王如兴 李库林.心肌缺血再灌注损伤中铁死亡的调控机制研究进展[J].心血管病学进展,2023,(5):416.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.008]
YE Yuheng,QIAN Lingling,WANG Ruxing,et al.Regulatory Mechanisms of Ferroptosis in Myocardial Ischemia Reperfusion Injury[J].Advances in Cardiovascular Diseases,2023,(4):416.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.008]